International Journal of Homoeopathic Sciences

Background: Osteoarthritis (OA) is one of the most prevalent forms of arthritis and a leading cause of physical disability globally. Conventional treatment options often involve long-term pharmacologic therapy or surgery, prompting interest in alternative modalities like homeopathy.

Objective: To assess the clinical efficacy of Rhus toxicodendron 1M in managing osteoarthritis symptoms using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and Naranjo criteria.

Methods: A retrospective observational study was conducted involving 30 patients diagnosed with primary OA of the knee or hip who were treated with Rhus tox 1M between January 2020 and January 2025. Patients were assessed using the WOMAC scale for pain, stiffness, and physical function before and after treatment. Causality of clinical improvement was evaluated using the Naranjo criteria adapted for homeopathy.
Results: Patients showed significant improvement in WOMAC scores post-treatment. The majority of patients reported reduced pain and improved physical functioning. Naranjo scoring indicated a probable relationship between the homeopathic intervention and clinical improvement.

Conclusion: Rhus toxicodendron 1M may offer a beneficial, cost-effective treatment option for OA, especially for populations seeking non-invasive and low-risk alternatives. Further controlled trials are recommended.